Group name
Non-NADT
Groups remarks
PCa Non-Low Risk Group
T2a
22 (7.2)
T2b
9 (2.9)
T2c
124 (40.5)
T3a
78 (25.5)
>T3b
72 (23.5)
T4
1 (0.3)
remark
Pathological stage:
GS
7 (7-8)